Cancer 12: Breast Cancer Flashcards
Describe the normal cellular organisation of the mammary gland
- Breast = only organ that develops after birth
- -> develops into fatty + glandular structure in puberty –> produce milk for neonate
- In breast fat –> tubular network comes together at nipple
Note: ANY part of breast/mammary gland can give rise to tumours
(majority = tumour of epithelial cells - carcinoma )
What are the 2 layers of epithelial cells of the breast?
- Inner epithelial layer contacting lumen (luminal epithelial cells)
- -> Have receptors (e.g. ER) – respond to hormone therapy - Deeper myo-epithelial cell layer (some = vacuolated) just around luminal cells - has contact w basement membrane
- -> Contract + push substances out of luminal cells into lumen
- Between tubule = fatty stromal cells
Incidence of BREAST CANCER is rising, but mortality falling due to:
- Earlier diagnosis – very important
- availability of Chemo/radiotherapies
- Hormonal therapies
What are the causes and risks of breast cancer?
- Early age of onset of menstruation (MOST IMP)
- Late age to menopause
- Age at 1st full-term pregnancy (early pregnancy is protective)
- Some forms of contraceptive pill (exposure to oestrogen)
- Hormone Replacement Therapy (^)
- Obesity
- Diet, physical activity, height, medication (Aspirin)
Describe the progression of normal breast –> to a malignant breast:
- Benign/carcinoma in situ - proliferation of luminal cells but myoepithelium = NOT breached (precancerous state)
- Lobular carcinoma – cancer tries to form tube-like structures, but fails - (behave normal)
- Medullary carcinoma – tumour cells have packed vesicles of hormones/peptides (abnormal)
- Infiltrating/invasive ductal carcinoma (IDC), many have no special type of histological structure = 80%/majority of breast cancers
immunohistochemical staining - using antibodies –> against human oestrogen receptor.
Oestrogen receptor grows in response to:
grows in response to oestrogen
note: 80% of breast cancers are Oestrogen receptor positive
- breast cancer growth is oestrogen regulated
ER is overexpressed / under expressed in most breast cancers
presence of ER is indicative of a better / worse prognosis
(How is this different in male breast cancer?)
ER is overexpressed in most breast cancers
presence of ER is indicative of a better prognosis
HOWEVER - WORSE prognosis in M breast cancer
What are the major treatment methods of breast cancer?
- Surgery (primary treatment)
- Endocrine therapy
- Adjuvant: given AFTER surgery
- Neo-adjuvant: used before to shrink tumour
- -> ovarian suppression
- -> blocks oestrogen production by enzymatic inhibition
- -> inhibits oestrogen responses - Radiation therapy
- Chemotherapy
How does Ovarian Ablation + Suppression work?
Ovarian Ablation:
- surgical oophorectomy
- ovarian irradiation
( but process = irreversible –> no long able to have children)
LHRH agonist:
- binds to LHRH receipts in pituitary –> cause receptor down regulation + suppresses LH release + inhibits ovarian function –> including oestrogen production
- fully reversible
e.g goserlein, buserelin, leuprolide
What are some ways to treat post menopausal breast cancer patients?
- Aromatase inhibitors –> less oestrogen made from androgens
- Antioestrogens that block ER in mammary gland
How do anti oestrogen work as treatment for breast cancer?
- Tamoxifen: acts as a competitive inhibitor of ER (nonsteroidal anti-oestrogen)
- binds to ER –> but inhibits action of ER
i. e Blocks stimulatory effects of oestrogen –> so cells held at G1 phase - Tamoxifen = used for metastatic disease in post-menopausal (1/3 of patients respond)
-
What are potential SE of Anti oestrogen?
such as Tamoxifen?
- hot flushes
- cataracts
- stroke
- DVT
- associated with endometrial thickening / hyperplasia
- thromboembolic episodes
What other effects does tamoxifen a SERM have on other systems?
a) effects on bone
b) effects on CVS
- tamoxifen = SERM
has:
- Oestrogenic effects in bone –> protects post-menopausal women against osteoporosis
- Oestrogenic effects on CVS –> lowers LDL + raises HDL –> decrease atherosclerosis risk in Females
- Toremifene = structural derivative of tamoxifen w/ similar anti-estrogenic + oestrogenic effects
- Faslodex = pure anti-oestrogen (anti-oestrogen in all tissues)
- -> effective in controlling oestrogen-stimulated growth:
- Raloxifene = antitumor agent in animals
o Agonist in bone but no activity in breast/uterus
o Used for osteoporosis in post-menopausal
-